2021 Annual Meeting

Session: Advances in New Modalities (Large Molecule, Oligos, Peptides, ADCs, Gene therapy, etc.) Product and Process Development (includes invited talks)

Co-Chair

Lee, B. W., GlaxoSmithKline

Presentations

03:30 PM

(360a) Analysis of Transformed Bioprocess Data and Application of Hybrid Modeling Approaches to Enhance Upstream Process Development
Mathis, K., Lee, B. W., Stevenson, D.

03:54 PM

(360b) Challenges in the Pharmaceutical Development of Lipid Nanoparticle Therapeutics
Viza, N., Wagner, A., Liu, Y., Zhao, A., Doty, A., Smith, K., Jia, X., Bothe, J., Su, Y., Li, M., Kemp, E., Socia, A., Guidry, E., Gindy, M.

04:42 PM

(360e) Dynamic Optimization of an Ultrafiltration System for the Concentration of Monoclonal Antibody Solutions Under Uncertainty
Rossi, F., Zuponcic, J., Ximenes, E., Geng, S., Tao, Y., Corvari, V., Ladisch, M., Reklaitis, G.

05:06 PM

(360f) Confocal Imaging of Protein Gel Layer Formation during Tangential Flow Filtration to Inform Process Conditions Reducing Protein Losses and Increasing Protein Concentration
Zuponcic, J., Rossi, F., Ximenes, E., Bruns, N., Geng, S., Tao, Y., Corvari, V., Reklaitis, G., Ladisch, M.